Skip to content

Alpha Mannosidosis Adult Form C5679974

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder where the body cannot break down certain complex sugars. It causes progressive neurological and physical symptoms. Treatment involves supportive care and enzyme therapy in some cases.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hearing loss

(metabolic)

Recurrent respiratory infections

(metabolic)

Mild intellectual disability

(metabolic)

Ataxia

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enzyme replacement therapy

Velmanase alfa (or equivalent recombinant human enzyme) administered via intravenous infusion to replace deficient alpha-mannosidase enzyme. Treatment aims to reduce substrate accumulation and slow disease progression in various organ systems.

medication
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Regular multidisciplinary surveillance

Comprehensive monitoring including annual MRI brain imaging, cardiac evaluation, hearing tests, and neurocognitive assessments. Regular ENT examinations and blood work to track disease progression and treatment response.

monitoring

Additional treatment options

Seizure management

Anticonvulsant medications such as levetiracetam or carbamazepine for patients experiencing seizure activity. Choice of agent depends on seizure type and tolerability profile.

medication

Physical and occupational therapy

Structured therapy programs to maintain muscle strength, joint mobility, and functional independence. Therapy focuses on balance training, gait optimization, and activities of daily living adaptation.

physical_therapy

Corrective ENT procedures

Surgical intervention for hearing loss including cochlear implantation when appropriate, or tonsillectomy/adenoidectomy for obstructive airway symptoms. Procedures address specific complications of the disease.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alpha Mannosidosis Adult Form C5679974?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Borgwardt L, Beck M, Parini R, Lee HM, Oxilia MA. Consensus recommendations for the diagnosis, management, and monitoring of alpha-mannosidosis. Orphanet J Rare Dis. 2022.

guideline2022
2

Malm D, Riise Stensland HM, Collins J, Jacobsen JC. Alpha-mannosidosis; pathophysiology and clinical manifestations. Mol Genet Metab. 2021.

review2021
3

Wraith JE, Cattini F, Gambacorti-Passerini C, Davidson J. Enzyme replacement therapy in adult alpha-mannosidosis: a prospective open-label study. J Inherit Metab Dis. 2020.

clinical_trial2020
4

Syrbe S, Blaufuss K, Mengel E, Huhn MH. Long-term outcomes in adult patients with alpha-mannosidosis. Orphanet J Rare Dis. 2023.

review2023

Medication Comparisons

Compare medications used to treat Alpha Mannosidosis Adult Form C5679974. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy